CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML
NCT05945849
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myeloid, Acute
Interventions
BIOLOGICAL:
CD33KO-HSPC; CART33
Sponsor
University of Pennsylvania